Novel Tryptamine Compounds as 5-HT2A Agonists for Treating Mood Disorders such as Depressive Disorders and Bipolar Disorders.

ACS Med Chem Lett • February 13, 2025 Peer reviewed • DOI: 10.1021/acsmedchemlett.5c00047 • via PubMed Central